The carcinogenic potential of tacrolimus ointment beyond immune suppression: a hypothesis creating case report

por Becker, Jürgen C, Houben, Roland, Vetter, Claudia S, Bröcker, Eva B
Publicado 2006

B-Raf specific antibody responses in melanoma patients

por Fensterle, Joachim, Becker, Jürgen C, Potapenko, Tamara, Heimbach, Veronika, Vetter, Claudia S, Bröcker, Eva B, Rapp, Ulf R
Publicado 2004

Assessment of the potential of the MET inhibitor tepotinib to affect the pharmacokinetics of CYP3A4 and P-gp substrates

por Yalkinoglu, Özkan, Becker, Andreas, Krebs-Brown, Axel, Vetter, Claudia, Lüpfert, Christian, Perrin, Dominique, Heuer, Jürgen, Biedert, Herlind, Hirt, Stefan, Bytyqi, Afrim, Bachmann, Angelika, Strotmann, Rainer
Publicado 2023

Phase 1 study in healthy participants of the safety, pharmacokinetics, and pharmacodynamics of enpatoran (M5049), a dual antagonist of toll‐like receptors 7 and 8

por Port, Andreas, Shaw, Jamie V., Klopp‐Schulze, Lena, Bytyqi, Afrim, Vetter, Claudia, Hussey, Elizabeth, Mammasse, Nadra, Ona, Victor, Bachmann, Angelika, Strugala, Denis, Reh, Christian, Goteti, Kosalaram
Publicado 2021